<DOC>
	<DOCNO>NCT00604123</DOCNO>
	<brief_summary>The purpose study evaluate clinical effectiveness , safety pharmacokinetics JNJ-17166864 patient seasonal allergic rhinitis .</brief_summary>
	<brief_title>A Study Evaluating Effects Intranasal JNJ-17166864 Symptoms Allergic Rhinitis Adults</brief_title>
	<detailed_description>The study conduct prove hypothesis JNJ-17466864 , compare placebo , provide 16 % great improvement nasal symptom seasonal allergic rhinitis . This randomized , blind , placebo-controlled , parallel-group , 2-center outpatient study adult men woman seasonal allergic rhinitis 2 year history ( longer ) mild moderate allergic reaction mountain cedar pollen . The study conduct mountain cedar pollen season . 72 qualified patient admit single-blind 7-day Run-in Period ( placebo twice daily ) establish Baseline allergic rhinitis symptom score . Patient eligibility enter double-blind treatment phase base patient ' baseline nasal symptom score . At least 66 eligible patient whose daytime average nasal symptom score ( nasal congestion , nasal itching , rhinorrhea , sneeze ) 2 great , daytime nasal congestion symptom score 2 great , least 4 7 Run-in day admit double-blind treatment phase , randomize either JNJ-17166864 placebo treatment group . During Treatment Phase , patient self-administer study medication ( 0.5 mg JNJ-17166864 placebo per nostril ) twice daily 2 week , record allergic rhinitis nasal ocular symptom score , complete Rhinoconjunctivitis Quality Life Questionnaire ( RQLQ ) , establish In-Treatment score . Pharmacokinetic biomarker sample collect treatment phase . Throughout study , safety tolerability assess .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Have clinical history seasonal allergic rhinitis onset offset nasal allergy symptom past 2 mountain cedar allergy season Have positive prick skin test reaction mountain cedar allergen screen document positive prick skin test within 12 month prior enter treatment phase Good general health basis physical examination ( include nasal examination ) , medical history , vital sign , 12lead ECG perform screen Day 2 Good general health basis clinical laboratory test perform screen Have history recent ( within 14 day prior study drug administration Day 1 ) common cold recent ( within 14 day prior study drug administration Day 1 ) occupational exposure inhale irritant ( e.g. , industrial gas , dust , pesticide ) exception mountain cedar pollen Have history recurrent frequent epistaxis recent episode ( within 14 day prior study drug administration Day 1 ) nose bleed Nonsmoker nontobacco user ( smoke cigarette use tobaccocontaining nicotinecontaining product least 3 month prior screen . Have asthma ( Note : subject mild intermittent asthma allow ) Chronic intermittent use inhale , oral , intramuscular , intravenous , and/or potent superpotent topical corticosteroid Use antihistamine study Under immunotherapy mountain cedar extract Using prohibit medication adequate washout period ( prior start Runin ) specify : Intranasal systemic corticosteroid ( 1 month ) , Intranasal cromolyn ( 2 week ) , Intranasal systemic decongestant ( 3 day ) , Intranasal systemic antihistamine ( 7 day ) , Intranasal tryptans , e.g . sumatryptan nasal spray , Imitrex ( 3 day ) , Intranasal ergotamines , e.g . dihydroergotamine mesylate nasal spray , Migranol ( 7 day ) , Singulair ( 7 day ) , NiaspanÂ® extendedrelease tablet , immediate release niacin ( 10 day ) Documented evidence acute significant chronic sinusitis , determine individual investigator Chronic use concomitant medication include prescription medication ( e.g. , tricyclic antidepressant ) would affect assessment effectiveness study medication within 14 day prior study drug administration Day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>JNJ-17166864</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>biomarkers</keyword>
	<keyword>rhinitis symptom</keyword>
	<keyword>mountain cedar pollen</keyword>
</DOC>